Replies to post #14312 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, I agree not much was learned. Nice to see an increase of over 25% in ACTH prescriptions for April over 2022. Especially with MNK projecting a decrease in Acthar revenue of between 15% and 20%. . I think we will see another guidance upgrade in August.